Activate Immunotherapy Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Out of Business

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Out of Business

Activate Immunotherapy General Information

Description

Operator of a clinical-stage immuno-oncology platform designed to treat solid tumors. The company's platform utilizes a novel approach for activating the body's immune system to recognize and destroy cancer cells, enabling physicians to treat cancer in their patients effectively.

Contact Information

Formerly Known As
NovaRx
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 8395 Camino Santa Fe Drive
  • Suite A
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 8395 Camino Santa Fe Drive
  • Suite A
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Activate Immunotherapy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 01-Nov-2019 Completed Out of Business
9. Later Stage VC 15-Aug-2016 Completed Generating Revenue
8. Merger/Acquisition 02-May-2016 Cancelled Generating Revenue
7. Later Stage VC (Series C) 01-Sep-2014 Completed Generating Revenue
6. Later Stage VC (Series D) 14-Mar-2007 Completed Generating Revenue
5. Grant 01-Jan-2007 Completed Generating Revenue
4. Later Stage VC (Series B) 26-Aug-2005 Completed Generating Revenue
3. Grant 12-May-2004 Completed Generating Revenue
2. Grant 01-Jan-2003 $2.63M Completed Generating Revenue
1. Grant 09-Sep-2002 $2.95M Completed Generating Revenue
To view Activate Immunotherapy’s complete valuation and funding history, request access »

Activate Immunotherapy Patents

Activate Immunotherapy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140194429-A1 Compositions for treatment of cancer Inactive 04-Jan-2013
US-20140194463-A1 Compositions for treatment of cancer Inactive 04-Jan-2013
US-20140194465-A1 Compositions for treatment of cancer Inactive 04-Jan-2013
US-20140194478-A1 Compositions for treatment of cancer Inactive 04-Jan-2013
US-20140194507-A1 Compositions for treatment of cancer Inactive 04-Jan-2013 C07D307/73
To view Activate Immunotherapy’s complete patent history, request access »

Activate Immunotherapy Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Activate Immunotherapy FAQs

  • When was Activate Immunotherapy founded?

    Activate Immunotherapy was founded in 1997.

  • Where is Activate Immunotherapy headquartered?

    Activate Immunotherapy is headquartered in San Diego, CA.

  • What is the size of Activate Immunotherapy?

    Activate Immunotherapy has 20 total employees.

  • What industry is Activate Immunotherapy in?

    Activate Immunotherapy’s primary industry is Drug Discovery.

  • Is Activate Immunotherapy a private or public company?

    Activate Immunotherapy is a Private company.

  • What is Activate Immunotherapy’s current revenue?

    The current revenue for Activate Immunotherapy is .

  • How much funding has Activate Immunotherapy raised over time?

    Activate Immunotherapy has raised $67.9M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »